Formation of Chitosan-Based Hydrogels Network - Chitosan Based Hydrogels: Functions and Applications - page 221

53. Andersson, M. and Löfroth, J. E. 2003. Small particles of a heparin/chitosan complex prepared
from a pharmaceutically acceptable microemulsion, Small particles of a heparin/chitosan
complex prepared from a pharmaceutically acceptable microemulsion. Int J Pharm 257:
305-309.
54. Kratz, G., Arnander, C., Swedenborg, J., Back, M., Falk, C., Gouda, I., and Larm, O. 1997.
Heparin-chitosan complexes stimulate wound healing in human skin. Scand J Plast Reconstr
Surg Hand Surg 31: 119-123.
55. Wang, X. H., Yan, Y. N., Liu, F., Xiong, Z., Wu, R., Zhang, R. J., and Lu, Q. P. 2005. Preparation
and characterization of a collagen/chitosan/heparin matrix for an implantable bioartificial
liver. J Biomater Sci Polymer Edn 16: 1063-1080.
56. Seo, S. J., Choi, Y. J., Akaike, T., Higuchi, A., and Cho, C. S. 2006. Alginate-galactosylated
chitosan-heparin scaffold as a new synthetic extracellular matrix for hepatocytes. Tissue Eng 12:
33-44.
57. Illum, L., Jabbal, G. I., Hinchcliffe, M., Fisher, A. N., and Davis, S. S. 2001. Chitosan as a novel
nasal delivery system for vaccines. Adv Drug Deliv Rev 51: 81-96.
58. Guliyeva, U., Oner, F., Ozsoy, S., and Haziroglu, R. 2006. Chitosan microparticles containing
plasmid DNA as potential oral gene delivery system. Eur J Pharm Biopharm 62: 17-25.
59. Zhu, D. W., Zhang, H. L., Bai, J. G., Liu, W. G., Leng, X. G., and Song, C. X. 2007. Enhancement
of transfection efficiency for HeLa cells via incorporating arginine moiety into chitosan. Chinese
Sci Bull 52: 3207-3215.
60. Gao, Y., Xu, Z. H., Chen, S. W., Gu, W. W., Chen, L. L., and Li, Y. P. 2008. Arginine-chitosan/
DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection effi-
ciency. Int J Pharm 359: 241-246.
61. Mansouri, S., Lavigne, P., Corsi, K., Benderdour, M., Beaumont, E., and Fernandes, J. C. 2004.
Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: Strategies to improve trans-
fection efficacy. Eur J Pharm Biopharm 57: 1-8.
62. Prabaharan, M. and Mano, J. F. 2005. Chitosan-based particles as controlled drug delivery
systems. Drug Deliv 12: 41-57.
63. Shu, X. Z. and Zhu, K. J. 2002. The influence of multivalent phosphate structure on the proper-
ties of ionically cross-linked chitosan films for controlled drug release. Eur J Pharm Biopharm 54:
235-243.
64. Aksungur, P., Sungur, A., Unal, S., Iskit, A. B., Squier, C. A., and Senel, S. 2004. Chitosan deliv-
ery systems for the treatment of oral mucositis: In vitro and in vivo studies. J Control Release 98:
269-279.
65. Aral, C. and Akbuga, J. 1998. Alternative approach to the preparation of chitosan beads. Int J
Pharm 168: 9-15.
66. Gupta, K. C. and Jabrail, F. H. 2007. Controlled-release formulations for hydroxy urea and
rifampicin using polyphosphate-anion-cross-linked chitosan microspheres. J Appl Polym Sci
104: 1942-1956.
67. Mi, F. L., Shyu, S. S., Wong, T. B., Jang, S. F., Lee, S. T., and Lu, K. T. 1999. Chitosan-polyelectrolyte
complexation for the preparation of gel beads and controlled release of anticancer drug. II.
Effect of pH-dependent ionic cross-linking or interpolymer complex using tripolyphosphate or
polyphosphate as reagent. J Appl Polym Sci 74: 1093-1107.
68. Cho, M. H., Kim, K. S., Ahn, H. H., Kim, M. S., Kim, S. H., and Khang, G. 2008. Chitosan gel as
an in situ -forming scaffold for rat bone marrow mesenchymal stem cells in vivo. Tissue Eng Part
A 14: 1099-1108.
69. Rayment, P. and Butler, M. F. 2008. Investigation of ionically cross-linked chitosan and chitosan-
bovine serum albumin beads for novel gastrointestinal functionality. J Appl Polym Sci 108:
2876-2885.
70. Gupta, K. C. and Jabrail, F. H. 2006. Preparation and characterization of sodium hexameta
phosphate cross-linked chitosan microspheres for controlled and sustained delivery of cen-
tchroman. Int J Biol Macromol 38: 272-283.